TY  - JOUR
AU  - Galldiks, Norbert
AU  - Verger, Antoine
AU  - Zaragori, Timothée
AU  - Unterrainer, Marcus
AU  - Suchorska, Bogdana
AU  - Lohman, Philipp
AU  - Tonn, Jörg C
AU  - Langen, Karl-Josef
AU  - Albert, Nathalie L
TI  - Comment on “Hypometabolic gliomas on FET-PET - Is there an inverted U-curve for survival?”, Kamson 2019, Neuro-Oncology
JO  - Neuro-Oncology
VL  - 21
IS  - 12
SN  - 1523-5866
CY  - Oxford
PB  - Oxford Univ. Press
M1  - FZJ-2019-04730
SP  - 1612-1613
PY  - 2019
AB  - With great interest we read the editorial by Kamson entitled “Hypometabolic Gliomas on FET-PET—Is There an Inverted U-Curve for Survival?” in Neuro-Oncology1 referring to our publication regarding the clinical relevance of photopenic defects on O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in glioma patients.2 In that paper, we identified within 100 patients with FET-PET–negative gliomas a subgroup of patients who even exhibit photopenic defects and had, moreover, an unfavorable outcome compared with gliomas with indifferent FET uptake (isometabolic gliomas). From our point of view, the frequency of photopenic defects is even lower than 10% (ie, ~5%). In his editorial, the author raised valuable new thoughts and ideas that are worth discussing.
LB  - PUB:(DE-HGF)16
C6  - pmid:31504819
UR  - <Go to ISI:>//WOS:000509393300018
DO  - DOI:10.1093/neuonc/noz173
UR  - https://juser.fz-juelich.de/record/865194
ER  -